ATR vs. RPRX: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at ATR and RPRX, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
Symbol | ATR | RPRX |
---|---|---|
Company Name | AptarGroup, Inc. | Royalty Pharma plc |
Country | United States | United States |
GICS Sector | Materials | Health Care |
GICS Industry | Containers & Packaging | Pharmaceuticals |
Market Capitalization | 9.19 billion USD | 21.03 billion USD |
Exchange | NYSE | NasdaqGS |
Listing Date | April 23, 1993 | June 16, 2020 |
Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of ATR and RPRX by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
Symbol | ATR | RPRX |
---|---|---|
5-Day Price Return | -0.85% | -0.69% |
13-Week Price Return | -11.84% | 10.31% |
26-Week Price Return | -4.72% | 7.90% |
52-Week Price Return | -7.14% | 26.93% |
Month-to-Date Return | -11.26% | -2.01% |
Year-to-Date Return | -11.24% | 41.36% |
10-Day Avg. Volume | 0.51M | 2.95M |
3-Month Avg. Volume | 0.40M | 4.08M |
3-Month Volatility | 26.53% | 19.83% |
Beta | 0.57 | 0.59 |
Profitability
Return on Equity (TTM)
ATR
15.28%
Containers & Packaging Industry
- Max
- 41.66%
- Q3
- 20.76%
- Median
- 14.35%
- Q1
- 6.55%
- Min
- 3.64%
ATR’s Return on Equity of 15.28% is on par with the norm for the Containers & Packaging industry, indicating its profitability relative to shareholder equity is typical for the sector.
RPRX
15.20%
Pharmaceuticals Industry
- Max
- 38.59%
- Q3
- 19.84%
- Median
- 11.90%
- Q1
- 5.63%
- Min
- -9.96%
RPRX’s Return on Equity of 15.20% is on par with the norm for the Pharmaceuticals industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
ATR
10.84%
Containers & Packaging Industry
- Max
- 11.61%
- Q3
- 8.17%
- Median
- 4.91%
- Q1
- 4.20%
- Min
- 0.08%
A Net Profit Margin of 10.84% places ATR in the upper quartile for the Containers & Packaging industry, signifying strong profitability and more effective cost management than most of its peers.
RPRX
44.28%
Pharmaceuticals Industry
- Max
- 34.51%
- Q3
- 17.73%
- Median
- 12.12%
- Q1
- 5.99%
- Min
- -7.73%
RPRX’s Net Profit Margin of 44.28% is exceptionally high, placing it well beyond the typical range for the Pharmaceuticals industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.
Operating Profit Margin (TTM)
ATR
14.30%
Containers & Packaging Industry
- Max
- 22.03%
- Q3
- 13.17%
- Median
- 8.87%
- Q1
- 6.86%
- Min
- 0.07%
An Operating Profit Margin of 14.30% places ATR in the upper quartile for the Containers & Packaging industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
RPRX
79.84%
Pharmaceuticals Industry
- Max
- 41.53%
- Q3
- 23.00%
- Median
- 16.24%
- Q1
- 9.24%
- Min
- -6.94%
RPRX’s Operating Profit Margin of 79.84% is exceptionally high, placing it well above the typical range for the Pharmaceuticals industry. This demonstrates outstanding efficiency in managing its core operations, which can be a result of strong pricing power or superior cost control.
Profitability at a Glance
Symbol | ATR | RPRX |
---|---|---|
Return on Equity (TTM) | 15.28% | 15.20% |
Return on Assets (TTM) | 8.49% | 5.66% |
Net Profit Margin (TTM) | 10.84% | 44.28% |
Operating Profit Margin (TTM) | 14.30% | 79.84% |
Gross Profit Margin (TTM) | 38.32% | -- |
Financial Strength
Current Ratio (MRQ)
ATR
1.21
Containers & Packaging Industry
- Max
- 2.13
- Q3
- 1.57
- Median
- 1.27
- Q1
- 1.13
- Min
- 0.58
ATR’s Current Ratio of 1.21 aligns with the median group of the Containers & Packaging industry, indicating that its short-term liquidity is in line with its sector peers.
RPRX
1.26
Pharmaceuticals Industry
- Max
- 4.49
- Q3
- 2.77
- Median
- 1.74
- Q1
- 1.26
- Min
- 0.11
RPRX’s Current Ratio of 1.26 falls into the lower quartile for the Pharmaceuticals industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
Debt-to-Equity Ratio (MRQ)
ATR
0.40
Containers & Packaging Industry
- Max
- 4.50
- Q3
- 2.23
- Median
- 1.22
- Q1
- 0.54
- Min
- 0.23
Falling into the lower quartile for the Containers & Packaging industry, ATR’s Debt-to-Equity Ratio of 0.40 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.
RPRX
1.26
Pharmaceuticals Industry
- Max
- 2.44
- Q3
- 1.07
- Median
- 0.42
- Q1
- 0.11
- Min
- 0.00
RPRX’s leverage is in the upper quartile of the Pharmaceuticals industry, with a Debt-to-Equity Ratio of 1.26. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.
Interest Coverage Ratio (TTM)
ATR
16.66
Containers & Packaging Industry
- Max
- 13.16
- Q3
- 8.10
- Median
- 3.61
- Q1
- 2.94
- Min
- 1.06
With an Interest Coverage Ratio of 16.66, ATR demonstrates a superior capacity to service its debt, placing it well above the typical range for the Containers & Packaging industry. This stems from either robust earnings or a conservative debt load.
RPRX
4.70
Pharmaceuticals Industry
- Max
- 103.95
- Q3
- 44.18
- Median
- 9.83
- Q1
- 2.82
- Min
- -42.71
RPRX’s Interest Coverage Ratio of 4.70 is positioned comfortably within the norm for the Pharmaceuticals industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
Symbol | ATR | RPRX |
---|---|---|
Current Ratio (MRQ) | 1.21 | 1.26 |
Quick Ratio (MRQ) | 0.83 | 1.26 |
Debt-to-Equity Ratio (MRQ) | 0.40 | 1.26 |
Interest Coverage Ratio (TTM) | 16.66 | 4.70 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
ATR
1.30%
Containers & Packaging Industry
- Max
- 7.37%
- Q3
- 4.07%
- Median
- 3.33%
- Q1
- 1.72%
- Min
- 0.00%
ATR’s Dividend Yield of 1.30% is in the lower quartile for the Containers & Packaging industry. This suggests the company’s strategy likely favors retaining earnings for growth over providing a high dividend income.
RPRX
1.76%
Pharmaceuticals Industry
- Max
- 6.98%
- Q3
- 3.32%
- Median
- 2.13%
- Q1
- 0.14%
- Min
- 0.00%
RPRX’s Dividend Yield of 1.76% is consistent with its peers in the Pharmaceuticals industry, providing a dividend return that is standard for its sector.
Dividend Payout Ratio (TTM)
ATR
30.51%
Containers & Packaging Industry
- Max
- 221.20%
- Q3
- 119.52%
- Median
- 58.05%
- Q1
- 28.91%
- Min
- 0.00%
ATR’s Dividend Payout Ratio of 30.51% is within the typical range for the Containers & Packaging industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
RPRX
36.87%
Pharmaceuticals Industry
- Max
- 165.20%
- Q3
- 90.59%
- Median
- 49.13%
- Q1
- 28.91%
- Min
- 0.00%
RPRX’s Dividend Payout Ratio of 36.87% is within the typical range for the Pharmaceuticals industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
Symbol | ATR | RPRX |
---|---|---|
Dividend Yield (TTM) | 1.30% | 1.76% |
Dividend Payout Ratio (TTM) | 30.51% | 36.87% |
Valuation
Price-to-Earnings Ratio (TTM)
ATR
23.49
Containers & Packaging Industry
- Max
- 35.98
- Q3
- 27.87
- Median
- 16.15
- Q1
- 14.38
- Min
- 8.20
ATR’s P/E Ratio of 23.49 is within the middle range for the Containers & Packaging industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
RPRX
21.00
Pharmaceuticals Industry
- Max
- 42.51
- Q3
- 26.88
- Median
- 19.11
- Q1
- 15.12
- Min
- 0.00
RPRX’s P/E Ratio of 21.00 is within the middle range for the Pharmaceuticals industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
ATR
2.55
Containers & Packaging Industry
- Max
- 2.91
- Q3
- 1.67
- Median
- 0.83
- Q1
- 0.64
- Min
- 0.30
ATR’s P/S Ratio of 2.55 is in the upper echelon for the Containers & Packaging industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.
RPRX
9.30
Pharmaceuticals Industry
- Max
- 7.55
- Q3
- 4.54
- Median
- 2.11
- Q1
- 1.52
- Min
- 0.00
With a P/S Ratio of 9.30, RPRX trades at a valuation that eclipses even the highest in the Pharmaceuticals industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.
Price-to-Book Ratio (MRQ)
ATR
3.83
Containers & Packaging Industry
- Max
- 5.28
- Q3
- 3.30
- Median
- 2.35
- Q1
- 1.57
- Min
- 0.89
ATR’s P/B Ratio of 3.83 is in the upper tier for the Containers & Packaging industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
RPRX
3.19
Pharmaceuticals Industry
- Max
- 9.78
- Q3
- 4.96
- Median
- 2.23
- Q1
- 1.46
- Min
- 0.60
RPRX’s P/B Ratio of 3.19 is within the conventional range for the Pharmaceuticals industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
Symbol | ATR | RPRX |
---|---|---|
Price-to-Earnings Ratio (TTM) | 23.49 | 21.00 |
Price-to-Sales Ratio (TTM) | 2.55 | 9.30 |
Price-to-Book Ratio (MRQ) | 3.83 | 3.19 |
Price-to-Free Cash Flow Ratio (TTM) | 26.92 | 17.80 |